-
1
-
-
0032168673
-
Clinical development of platinum complexes in cancer therapy: an historical perspective and an update
-
Lebwohl D., Canetta R. Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur. J. Cancer 1998, 34:1522-1534.
-
(1998)
Eur. J. Cancer
, vol.34
, pp. 1522-1534
-
-
Lebwohl, D.1
Canetta, R.2
-
2
-
-
0037007094
-
Curing metastatic testicular cancer
-
Einhorn L.H. Curing metastatic testicular cancer. Proc. Natl. Acad. Sci. USA 2002, 99:4592-4595.
-
(2002)
Proc. Natl. Acad. Sci. USA
, vol.99
, pp. 4592-4595
-
-
Einhorn, L.H.1
-
3
-
-
0032169105
-
Cellular and molecular determinants of cisplatin resistance
-
Pérez R.P. Cellular and molecular determinants of cisplatin resistance. Eur. J. Cancer 1998, 34:1535-1544.
-
(1998)
Eur. J. Cancer
, vol.34
, pp. 1535-1544
-
-
Pérez, R.P.1
-
4
-
-
0031982327
-
Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines
-
Burger H., Nooter K., Kortland C., Stoker G. Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines. Bri. J. Cancer 1998, 77:1562-1567.
-
(1998)
Bri. J. Cancer
, vol.77
, pp. 1562-1567
-
-
Burger, H.1
Nooter, K.2
Kortland, C.3
Stoker, G.4
-
5
-
-
0031443744
-
Cisplatin resistance and DNA repair
-
Crul M., Schellens J., Beijnen J., Maliepaard M. Cisplatin resistance and DNA repair. Cancer Treat. Rev. 1997, 23:341-366.
-
(1997)
Cancer Treat. Rev.
, vol.23
, pp. 341-366
-
-
Crul, M.1
Schellens, J.2
Beijnen, J.3
Maliepaard, M.4
-
6
-
-
0033134778
-
Cyclin-dependent kinase and Cks/Suc1 interact with the proteasome in yeast to control proteolysis of M-phase targets
-
Kaiser P., Moncollin V., Clarke D.J., Watson M.H., Bertolaet B.L., Reed S.I., Bailly E. Cyclin-dependent kinase and Cks/Suc1 interact with the proteasome in yeast to control proteolysis of M-phase targets. Genes Dev. 1999, 13:1190-1202.
-
(1999)
Genes Dev.
, vol.13
, pp. 1190-1202
-
-
Kaiser, P.1
Moncollin, V.2
Clarke, D.J.3
Watson, M.H.4
Bertolaet, B.L.5
Reed, S.I.6
Bailly, E.7
-
7
-
-
0034084163
-
Phosphorylation meets ubiquitination: the control of NF-κB activity
-
Karin M., Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 2000, 18:621-663.
-
(2000)
Annu. Rev. Immunol.
, vol.18
, pp. 621-663
-
-
Karin, M.1
Ben-Neriah, Y.2
-
8
-
-
0029838640
-
ER degradation of a misfolded luminal protein by the cytosolic ubiquitin-proteasome pathway
-
Hiller M.M., Finger A., Schweiger M., Wolf D.H. ER degradation of a misfolded luminal protein by the cytosolic ubiquitin-proteasome pathway. Science 1996, 273:1725-1728.
-
(1996)
Science
, vol.273
, pp. 1725-1728
-
-
Hiller, M.M.1
Finger, A.2
Schweiger, M.3
Wolf, D.H.4
-
9
-
-
0035487184
-
Effect of the proteasome inhibitor ALLnL on cisplatin sensitivity in human ovarian tumor cells
-
Yunmbam M.K., Li Q.Q., Mimnaugh E.G., Kayastha G.L., Yu J.J., Jones L.N., Neckers L., Reed E. Effect of the proteasome inhibitor ALLnL on cisplatin sensitivity in human ovarian tumor cells. Int. J. Oncol. 2001, 19:741-748.
-
(2001)
Int. J. Oncol.
, vol.19
, pp. 741-748
-
-
Yunmbam, M.K.1
Li, Q.Q.2
Mimnaugh, E.G.3
Kayastha, G.L.4
Yu, J.J.5
Jones, L.N.6
Neckers, L.7
Reed, E.8
-
10
-
-
0004920274
-
Lactacystin enhances cisplatin sensitivity in resistant human ovarian cancer cell lines via inhibition of DNA repair and ERCC-1 expression
-
Li Q.Q., Yunmbam M.K., Zhong X., Yu J.J., Mimnaugh E.G., Neckers L., Reed E. Lactacystin enhances cisplatin sensitivity in resistant human ovarian cancer cell lines via inhibition of DNA repair and ERCC-1 expression. Cell Mol. Biol. 2001, 47:61-72.
-
(2001)
Cell Mol. Biol.
, vol.47
, pp. 61-72
-
-
Li, Q.Q.1
Yunmbam, M.K.2
Zhong, X.3
Yu, J.J.4
Mimnaugh, E.G.5
Neckers, L.6
Reed, E.7
-
11
-
-
71749119515
-
Proteasome inhibitors prevent cisplatin-induced mitochondrial release of apoptosis- inducing factor and markedly ameliorate cisplatin nephrotoxicity
-
Ling L.B., Cheng Y.N., Christian H.B., Rohit S.B., Gur P. Proteasome inhibitors prevent cisplatin-induced mitochondrial release of apoptosis- inducing factor and markedly ameliorate cisplatin nephrotoxicity. Biochem. Pharmacol. 2010, 79:137-146.
-
(2010)
Biochem. Pharmacol.
, vol.79
, pp. 137-146
-
-
Ling, L.B.1
Cheng, Y.N.2
Christian, H.B.3
Rohit, S.B.4
Gur, P.5
-
12
-
-
0001842889
-
Programmed cell death and the proteasome
-
Drexler H.C.A. Programmed cell death and the proteasome. Apoptosis 1998, 3:1-7.
-
(1998)
Apoptosis
, vol.3
, pp. 1-7
-
-
Drexler, H.C.A.1
-
13
-
-
0032513215
-
Proteasome inhibitors activate stress kinases and induce Hsp72. Diverse effects on apoptosis
-
Meriin A.B., Gabai V.L., Yaglom J., Shifrin V.I., Sherman M.Y. Proteasome inhibitors activate stress kinases and induce Hsp72. Diverse effects on apoptosis. J. Biol. Chem. 1998, 273:6373-6379.
-
(1998)
J. Biol. Chem.
, vol.273
, pp. 6373-6379
-
-
Meriin, A.B.1
Gabai, V.L.2
Yaglom, J.3
Shifrin, V.I.4
Sherman, M.Y.5
-
14
-
-
77950857972
-
Apoptosis in yeast: triggers, pathways, subroutines
-
Carmona-Gutierrez D., Eisenberg T., Büttner S., Meisinger C., Kroemer G., Madeo F. Apoptosis in yeast: triggers, pathways, subroutines. Cell Death Differ. 2010, 17(5):763-773.
-
(2010)
Cell Death Differ.
, vol.17
, Issue.5
, pp. 763-773
-
-
Carmona-Gutierrez, D.1
Eisenberg, T.2
Büttner, S.3
Meisinger, C.4
Kroemer, G.5
Madeo, F.6
-
15
-
-
0035195557
-
The evolution of diverse biological responses to DNA damage: insights from yeast and p53
-
Wahl G.M., Carr A.M. The evolution of diverse biological responses to DNA damage: insights from yeast and p53. Nat. Cell Biol. 2001, 3(12):E277-E286.
-
(2001)
Nat. Cell Biol.
, vol.3
, Issue.12
-
-
Wahl, G.M.1
Carr, A.M.2
-
16
-
-
34247574716
-
Proteasome inhibition in wild-type yeast Saccharomyces cerevisiae
-
Liu C., Apodaka J., Davis L., Rao H. Proteasome inhibition in wild-type yeast Saccharomyces cerevisiae. Biotechniques 2007, 42:158-162.
-
(2007)
Biotechniques
, vol.42
, pp. 158-162
-
-
Liu, C.1
Apodaka, J.2
Davis, L.3
Rao, H.4
-
17
-
-
0007048825
-
Cell cycle analysis of yeasts
-
Chapter 11:Unit 11. 13.
-
Fortuna M., Sousa M.J., Côrte-Real M., Leão C., Salvador A., Sansonetty F. Cell cycle analysis of yeasts. Curr. Protoc. Cytom. 2001, Chapter 11:Unit 11. 13.
-
(2001)
Curr. Protoc. Cytom.
-
-
Fortuna, M.1
Sousa, M.J.2
Côrte-Real, M.3
Leão, C.4
Salvador, A.5
Sansonetty, F.6
-
18
-
-
0030667206
-
A yeast mutant showing diagnostic markers of early and late apoptosis
-
Madeo F., Frohlich E., Frohlich K. A yeast mutant showing diagnostic markers of early and late apoptosis. J. Cell Biol. 1997, 139:729-734.
-
(1997)
J. Cell Biol.
, vol.139
, pp. 729-734
-
-
Madeo, F.1
Frohlich, E.2
Frohlich, K.3
-
19
-
-
0034468736
-
Role of reactive oxygen species (ROS) in apoptosis induction
-
Simon H.U., Haj-Yehia A., Levi-Schaffer F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 2000, 5(5):415-418.
-
(2000)
Apoptosis
, vol.5
, Issue.5
, pp. 415-418
-
-
Simon, H.U.1
Haj-Yehia, A.2
Levi-Schaffer, F.3
-
20
-
-
0033563646
-
A novel apoptosis-like pathway, independent of mitochondria and caspases, induced by curcumin in human lymphoblastoid T (Jurkat) cells
-
Piwocka K., Zabłocki K., Wieckowski M.R., Skierski J., Feiga I., Szopa J., Drela N., Wojtczak L., Sikora E. A novel apoptosis-like pathway, independent of mitochondria and caspases, induced by curcumin in human lymphoblastoid T (Jurkat) cells. Exp. Cell Res. 1999, 15(2492):299-307.
-
(1999)
Exp. Cell Res.
, vol.15
, Issue.2492
, pp. 299-307
-
-
Piwocka, K.1
Zabłocki, K.2
Wieckowski, M.R.3
Skierski, J.4
Feiga, I.5
Szopa, J.6
Drela, N.7
Wojtczak, L.8
Sikora, E.9
-
21
-
-
84866753909
-
Independent transcriptional reprogramming and apoptosis induction by cisplatin
-
Galluzzi L., Vitale I., Senovilla L., Eisenberg T., Carmona-Gutierrez D., Vacchelli E., Robert T., Ripoche H., Jägemann N., Paccard C., Servant N., Hupé P., Lazar V., Dessen P., Barillot E., Zischka H., Madeo F., Kroemer G. Independent transcriptional reprogramming and apoptosis induction by cisplatin. Cell Cycle 2012, 11:3472-3480.
-
(2012)
Cell Cycle
, vol.11
, pp. 3472-3480
-
-
Galluzzi, L.1
Vitale, I.2
Senovilla, L.3
Eisenberg, T.4
Carmona-Gutierrez, D.5
Vacchelli, E.6
Robert, T.7
Ripoche, H.8
Jägemann, N.9
Paccard, C.10
Servant, N.11
Hupé, P.12
Lazar, V.13
Dessen, P.14
Barillot, E.15
Zischka, H.16
Madeo, F.17
Kroemer, G.18
-
22
-
-
78651491709
-
Ubiquitin-proteasome genes as targets for modulation of cisplatin sensitivity in fission yeast
-
Gatti L., Hoe K.L., Hayles J., Righetti S.C., Carenini N., Dal Bo L., Kim D.U., Park H.O., Perego P. Ubiquitin-proteasome genes as targets for modulation of cisplatin sensitivity in fission yeast. BMC Genomics 2011, 12:44.
-
(2011)
BMC Genomics
, vol.12
, pp. 44
-
-
Gatti, L.1
Hoe, K.L.2
Hayles, J.3
Righetti, S.C.4
Carenini, N.5
Dal Bo, L.6
Kim, D.U.7
Park, H.O.8
Perego, P.9
-
23
-
-
81055156663
-
A new high resolution screening method for study of phenotype stress responses of Saccharomyces cerevisae mutants
-
Sletta H., Klinkenberg G., Winnberg A., Kvitvang H.F., Nilsen M.B., Krokan H.E., Otterlei M., Bruheim P. A new high resolution screening method for study of phenotype stress responses of Saccharomyces cerevisae mutants. J. Microbiol. Methods 2011, 87(3):363-367.
-
(2011)
J. Microbiol. Methods
, vol.87
, Issue.3
, pp. 363-367
-
-
Sletta, H.1
Klinkenberg, G.2
Winnberg, A.3
Kvitvang, H.F.4
Nilsen, M.B.5
Krokan, H.E.6
Otterlei, M.7
Bruheim, P.8
-
24
-
-
21344433235
-
Genome-wide screen identifies genes whose inactivation confer resistance to cisplatin in Saccharomyces cerevisiae
-
Huang R.Y., Eddy M., Vujcic M., Kowalski D. Genome-wide screen identifies genes whose inactivation confer resistance to cisplatin in Saccharomyces cerevisiae. Cancer Res. 2005, 65(13):5890-5897.
-
(2005)
Cancer Res.
, vol.65
, Issue.13
, pp. 5890-5897
-
-
Huang, R.Y.1
Eddy, M.2
Vujcic, M.3
Kowalski, D.4
-
25
-
-
20344366589
-
Small-molecule inhibitors of proteasome activity
-
Gaczynska M., Osmulski P.A. Small-molecule inhibitors of proteasome activity. Methods Mol. Biol. 2005, 301:3-22.
-
(2005)
Methods Mol. Biol.
, vol.301
, pp. 3-22
-
-
Gaczynska, M.1
Osmulski, P.A.2
-
26
-
-
55449118522
-
Genome-wide requirements for resistance to functionally distinct DNA-damaging agents
-
Lee W., St R.P., Onge M., Proctor P., Flaherty M., Jordan I., Arkin A.P., Davis R.W., Nislow C., Giaever G. Genome-wide requirements for resistance to functionally distinct DNA-damaging agents. PLoS Genet. 2005, 1(2):e24.
-
(2005)
PLoS Genet.
, vol.1
, Issue.2
-
-
Lee, W.1
St, R.P.2
Onge, M.3
Proctor, P.4
Flaherty, M.5
Jordan, I.6
Arkin, A.P.7
Davis, R.W.8
Nislow, C.9
Giaever, G.10
-
27
-
-
2542541217
-
Genome-wide identification of genes conferring resistance to the anticancer agents cisplatin, oxaliplatin, and mitomycin, C
-
Wu H.I., Brown J.A., Dorie M.J., Lazzeroni L., Brown J.M. Genome-wide identification of genes conferring resistance to the anticancer agents cisplatin, oxaliplatin, and mitomycin, C. Cancer Res. 2004, 64(11):3940-3948.
-
(2004)
Cancer Res.
, vol.64
, Issue.11
, pp. 3940-3948
-
-
Wu, H.I.1
Brown, J.A.2
Dorie, M.J.3
Lazzeroni, L.4
Brown, J.M.5
-
28
-
-
34147118520
-
An atypical active cell death process underlies the fungicidal activity of ciclopirox olamine against the yeast Saccharomyces cerevisiae
-
Almeida B., Sampaio-Marques B., Carvalho J., Silva M.T., Leão C., Rodrigues F., Ludovico P. An atypical active cell death process underlies the fungicidal activity of ciclopirox olamine against the yeast Saccharomyces cerevisiae. FEMS Yeast Res. 2007, 7:404-412.
-
(2007)
FEMS Yeast Res.
, vol.7
, pp. 404-412
-
-
Almeida, B.1
Sampaio-Marques, B.2
Carvalho, J.3
Silva, M.T.4
Leão, C.5
Rodrigues, F.6
Ludovico, P.7
-
29
-
-
0035060354
-
Is cisplatin-induced cell death always produced by apoptosis?
-
Gonzalez V.M., Fuertez M.A., Alonso C., Perez J.W. Is cisplatin-induced cell death always produced by apoptosis?. Mol. Pharmacol. 2001, 59:657-663.
-
(2001)
Mol. Pharmacol.
, vol.59
, pp. 657-663
-
-
Gonzalez, V.M.1
Fuertez, M.A.2
Alonso, C.3
Perez, J.W.4
-
30
-
-
79960981382
-
Necrotic concentrations of cisplatin activate the apoptotic machinery but inhibit effector caspases and interfere with the execution of apoptosis
-
Sancho-Martínez S.M., Piedrafita F.J., Cannata-Andía J.B., López-Novoa J.M., López-Hernández F.J. Necrotic concentrations of cisplatin activate the apoptotic machinery but inhibit effector caspases and interfere with the execution of apoptosis. Toxicol. Sci. 2011, 122:73-85.
-
(2011)
Toxicol. Sci.
, vol.122
, pp. 73-85
-
-
Sancho-Martínez, S.M.1
Piedrafita, F.J.2
Cannata-Andía, J.B.3
López-Novoa, J.M.4
López-Hernández, F.J.5
-
31
-
-
34447635894
-
Mcl-1 is downregulated in cisplatin-induced apoptosis, and proteasome inhibitors restore Mcl-1 and promote survival in renal tubular epithelial cells
-
Yang C., Kaushal V., Shah S.V., Kaushal G.P. Mcl-1 is downregulated in cisplatin-induced apoptosis, and proteasome inhibitors restore Mcl-1 and promote survival in renal tubular epithelial cells. Am. J. Physiol. Renal Physiol. 2007, 292:1710-1717.
-
(2007)
Am. J. Physiol. Renal Physiol.
, vol.292
, pp. 1710-1717
-
-
Yang, C.1
Kaushal, V.2
Shah, S.V.3
Kaushal, G.P.4
-
32
-
-
71749119515
-
Proteasome inhibitors prevent cisplatin-induced mitochondrial release of apoptosis-inducing factor and markedly ameliorate cisplatin nephrotoxicity
-
Liu L., Yang C., Herzog C., Seth R., Kaushal G.P. Proteasome inhibitors prevent cisplatin-induced mitochondrial release of apoptosis-inducing factor and markedly ameliorate cisplatin nephrotoxicity. Biochem. Pharmacol. 2010, 79:137-146.
-
(2010)
Biochem. Pharmacol.
, vol.79
, pp. 137-146
-
-
Liu, L.1
Yang, C.2
Herzog, C.3
Seth, R.4
Kaushal, G.P.5
-
33
-
-
84872872660
-
Sequential effects of the proteasome inhibitor bortezomib and chemotherapeutic agents in uterine cervical cancer cell lines
-
Miyamoto Y., Nakagawa S., Wada-Hiraike O., Seiki T., Tanikawa M., Hiraike H., Sone K., Nagasaka K., Oda K., Kawana K., Nakagawa K., Fujii T., Yano T., Kozuma S., Taketani Y. Sequential effects of the proteasome inhibitor bortezomib and chemotherapeutic agents in uterine cervical cancer cell lines. Oncol. Rep. 2013, 29:51-57.
-
(2013)
Oncol. Rep.
, vol.29
, pp. 51-57
-
-
Miyamoto, Y.1
Nakagawa, S.2
Wada-Hiraike, O.3
Seiki, T.4
Tanikawa, M.5
Hiraike, H.6
Sone, K.7
Nagasaka, K.8
Oda, K.9
Kawana, K.10
Nakagawa, K.11
Fujii, T.12
Yano, T.13
Kozuma, S.14
Taketani, Y.15
-
34
-
-
59449105383
-
Enhanced delivery of cisplatin to intraperitoneal ovarian carcinomas mediated by the effects of bortezomib on the human copper transporter 1
-
Jandial D.D., Farshchi-Heydari S., Larson C.A., Elliot G.I., Wrasidlo W.J., Howell S.B. Enhanced delivery of cisplatin to intraperitoneal ovarian carcinomas mediated by the effects of bortezomib on the human copper transporter 1. Clin. Cancer Res. 2009, 15:553-560.
-
(2009)
Clin. Cancer Res.
, vol.15
, pp. 553-560
-
-
Jandial, D.D.1
Farshchi-Heydari, S.2
Larson, C.A.3
Elliot, G.I.4
Wrasidlo, W.J.5
Howell, S.B.6
-
35
-
-
49849104202
-
Bortezomib induces apoptosis via Bim and Bik up-regulation and synergizes with cisplatin in the killing of head and neck squamous cell carcinoma cells
-
Li C., Li R., Grandis J.R., Johnson D.E. Bortezomib induces apoptosis via Bim and Bik up-regulation and synergizes with cisplatin in the killing of head and neck squamous cell carcinoma cells. Mol. Cancer Ther. 2008, 7:1647-1655.
-
(2008)
Mol. Cancer Ther.
, vol.7
, pp. 1647-1655
-
-
Li, C.1
Li, R.2
Grandis, J.R.3
Johnson, D.E.4
-
36
-
-
2942536377
-
Yeast as a model system for anticancer drug discovery
-
Simon J.A., Bedalov A. Yeast as a model system for anticancer drug discovery. Nat. Rev. Cancer. 2004, 4:481-487.
-
(2004)
Nat. Rev. Cancer.
, vol.4
, pp. 481-487
-
-
Simon, J.A.1
Bedalov, A.2
-
37
-
-
84857642093
-
New insights into cancer-related proteins provided by the yeast model
-
Pereira C., Coutinho I., Soares J., Bessa C., Leão M., Saraiva L. New insights into cancer-related proteins provided by the yeast model. FEBS J. 2012, 279:697-712.
-
(2012)
FEBS J.
, vol.279
, pp. 697-712
-
-
Pereira, C.1
Coutinho, I.2
Soares, J.3
Bessa, C.4
Leão, M.5
Saraiva, L.6
-
38
-
-
79953684503
-
The Warburg and Crabtree effects: on the origin of cancer cell energy metabolism and of yeast glucose repression
-
Diaz-Ruiz R., Rigoulet M., Devin A. The Warburg and Crabtree effects: on the origin of cancer cell energy metabolism and of yeast glucose repression. Biochim. Biophys. Acta 2011, 1807(6):568-576.
-
(2011)
Biochim. Biophys. Acta
, vol.1807
, Issue.6
, pp. 568-576
-
-
Diaz-Ruiz, R.1
Rigoulet, M.2
Devin, A.3
-
39
-
-
2642621649
-
Protein kinase activity associated with the product of the yeast cell division cycle gene CDC28
-
Reed S.I., Hadwiger J.A., Lorincz A.T. Protein kinase activity associated with the product of the yeast cell division cycle gene CDC28. Proc. Natl. Acad. Sci. 1985, 82:4055-4059.
-
(1985)
Proc. Natl. Acad. Sci.
, vol.82
, pp. 4055-4059
-
-
Reed, S.I.1
Hadwiger, J.A.2
Lorincz, A.T.3
-
40
-
-
0035947238
-
The 19S regulatory particle of the proteasome is required for efficient transcription elongation by RNA polymerase II
-
Ferdous A., Gonzalez F., Sun L., Kodadek T., Johnston S.A. The 19S regulatory particle of the proteasome is required for efficient transcription elongation by RNA polymerase II. Mol. Cell 2001, 7:981-991.
-
(2001)
Mol. Cell
, vol.7
, pp. 981-991
-
-
Ferdous, A.1
Gonzalez, F.2
Sun, L.3
Kodadek, T.4
Johnston, S.A.5
-
41
-
-
0033672549
-
Mitochondria-targeted green fluorescent proteins: convenient tools for the study of organelle biogenesis in Saccharomyces cerevisiae
-
Westermann B., Neupert W. Mitochondria-targeted green fluorescent proteins: convenient tools for the study of organelle biogenesis in Saccharomyces cerevisiae. Yeast 2000, 16:1421-1427.
-
(2000)
Yeast
, vol.16
, pp. 1421-1427
-
-
Westermann, B.1
Neupert, W.2
|